The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Naloxone Hydrochloride Minijet 400 micrograms/ml Solution for injection

DLRC Pharma Services LimitedPA22684/003/001

Main Information

Trade NameNaloxone Hydrochloride Minijet 400 micrograms/ml Solution for injection
Dosage FormSolution for injection
Licence HolderDLRC Pharma Services Limited
Licence NumberPA22684/003/001

Group Information

ATC CodeV03AB Antidotes
V03AB15 naloxone


License statusWithdrawn
Withdrawn Date19/12/2023
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back